CPH 0.00% 29.0¢ creso pharma limited

Creso Pharma is on an upward trajectory due to its excellent products

  1. 230 Posts.
    lightbulb Created with Sketch. 8
    Creso Pharma CPH at this present time is all about expected future performance and the licensing of its medicinal cannabis products for humans. Already this is happening in Europe. Back in January CPH announced to have obtained the necessary regulatory approval for cannaQIX in the UK and to partner with Precision Healthcare for its distribution – both significant milestones. In the ASX the pharmaceuticals industry is project to have an annual growth of 56.7%. We think CPH will be part of this huge growth spurt this year. CPH has no debt and its SP is on an upward trajectory, hopefully penetrating above $1.
watchlist Created with Sketch. Add CPH (ASX) to my watchlist
(20min delay)
Mkt cap ! $43.94M
Open High Low Value Volume
29.0¢ 29.0¢ 28.5¢ $51.80K 179.4K

Buyers (Bids)

No. Vol. Price($)
8 174501 28.5¢

Sellers (Offers)

Price($) Vol. No.
29.0¢ 40063 6
View Market Depth
Last trade - 14.36pm 22/10/2019 (20 minute delay) ?
0.000 ( 1.72 %)
Open High Low Volume
29.0¢ 29.0¢ 28.5¢ 62945
Last updated 15.00pm 22/10/2019 (live) ?
CPH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.